251 related articles for article (PubMed ID: 29367410)
1. Impact of the financial crisis on COPD burden: Greece as a case study.
Kotsiou OS; Zouridis S; Kosmopoulos M; Gourgoulianis KI
Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29367410
[TBL] [Abstract][Full Text] [Related]
2. The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece.
Souliotis K; Kousoulakou H; Hillas G; Tzanakis N; Toumbis M; Vassilakopoulos T
Int J Chron Obstruct Pulmon Dis; 2017; 12():1395-1400. PubMed ID: 28546747
[TBL] [Abstract][Full Text] [Related]
3. The pharmacological cost of COPD during Greek economic crisis.
Stafyla E; Kerenidi T; Gerogianni I; Geitona M; Daniil Z; Gourgoulianis KI
Int J Chron Obstruct Pulmon Dis; 2017; 12():461-466. PubMed ID: 28203069
[TBL] [Abstract][Full Text] [Related]
4. The annual direct costs of stable COPD in Greece.
Stafyla E; Geitona M; Kerenidi T; Economou A; Daniil Z; Gourgoulianis KI
Int J Chron Obstruct Pulmon Dis; 2018; 13():309-315. PubMed ID: 29398912
[TBL] [Abstract][Full Text] [Related]
5. Sex discrepancies in COPD patients and burden of the disease in females: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study).
Papaioannou AI; Bania E; Alexopoulos EC; Mitsiki E; Malli F; Gourgoulianis KI
Int J Chron Obstruct Pulmon Dis; 2014; 9():203-13. PubMed ID: 24600217
[TBL] [Abstract][Full Text] [Related]
6. Health status of patients who suffer from acute and chronic respiratory diseases in Greece in the era of economic crisis.
Koutsimpou P; Gourgoulianis K; Economou A; Raftopoulos V
Adv Respir Med; 2019; 87(3):167-174. PubMed ID: 31282558
[TBL] [Abstract][Full Text] [Related]
7. Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review.
Iheanacho I; Zhang S; King D; Rizzo M; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2020; 15():439-460. PubMed ID: 32161455
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of COPD in a Swedish cohort: the ARCTIC study.
Lisspers K; Larsson K; Johansson G; Janson C; Costa-Scharplatz M; Gruenberger JB; Uhde M; Jorgensen L; Gutzwiller FS; Ställberg B
Int J Chron Obstruct Pulmon Dis; 2018; 13():275-285. PubMed ID: 29391785
[TBL] [Abstract][Full Text] [Related]
9. Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET.
Byng D; Lutter JI; Wacker ME; Jörres RA; Liu X; Karrasch S; Schulz H; Vogelmeier C; Holle R
Int J Chron Obstruct Pulmon Dis; 2019; 14():1423-1439. PubMed ID: 31308648
[TBL] [Abstract][Full Text] [Related]
10. The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease.
Souliotis K; Silva Miguel L; Hillas G; Borges M; Papageorgiou G; Viana D; Malhadeiro J; Soulard S
Ther Adv Respir Dis; 2020; 14():1753466620926802. PubMed ID: 32519591
[TBL] [Abstract][Full Text] [Related]
11. The global impact of non-communicable diseases on households and impoverishment: a systematic review.
Jaspers L; Colpani V; Chaker L; van der Lee SJ; Muka T; Imo D; Mendis S; Chowdhury R; Bramer WM; Falla A; Pazoki R; Franco OH
Eur J Epidemiol; 2015 Mar; 30(3):163-88. PubMed ID: 25527371
[TBL] [Abstract][Full Text] [Related]
12. The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data.
Kim J; Rhee CK; Yoo KH; Kim YS; Lee SW; Park YB; Lee JH; Oh Y; Lee SD; Kim Y; Kim K; Yoon H
Int J Chron Obstruct Pulmon Dis; 2013; 8():561-8. PubMed ID: 24277985
[TBL] [Abstract][Full Text] [Related]
13. COPD management costs according to the frequency of COPD exacerbations in UK primary care.
Punekar YS; Shukla A; Müllerova H
Int J Chron Obstruct Pulmon Dis; 2014; 9():65-73. PubMed ID: 24426781
[TBL] [Abstract][Full Text] [Related]
14. Effect of the economic crisis on the use of health and home care services among Spanish COPD patients.
de Miguel-Diez J; Lopez-de-Andres A; Herandez-Barrera V; Jimenez-Trujillo I; Puente-Maestu L; Cerezo-Lajas A; Jimenez-Garcia R
Int J Chron Obstruct Pulmon Dis; 2018; 13():725-739. PubMed ID: 29535513
[TBL] [Abstract][Full Text] [Related]
15. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations.
Khoudigian-Sinani S; Kowal S; Suggett JA; Coppolo DP
Int J Chron Obstruct Pulmon Dis; 2017; 12():3065-3073. PubMed ID: 29089755
[TBL] [Abstract][Full Text] [Related]
17. Impact of income status on prognosis of acute coronary syndrome patients during Greek financial crisis.
Andrikopoulos G; Tzeis S; Terentes-Printzios D; Varounis C; Vlachopoulos C; Mantas I; Patsilinakos S; Lampropoulos S; Olympios C; Kartalis A; Manolis A; Gotsis A; Triposkiadis F; Tsaknakis T; Goudevenos I; Kaprinis I; Pras A; Vasiliou F; Skoumpourdis E; Sakka G; Draganigos A; Vardas P
Clin Res Cardiol; 2016 Jun; 105(6):518-26. PubMed ID: 26658679
[TBL] [Abstract][Full Text] [Related]
18. Cost of Severe Chronic Obstructive Pulmonary Disease Exacerbations in a High Burden Region in North India.
Koul PA; Nowshehr AA; Khan UH; Jan RA; Shah SU
Ann Glob Health; 2019 Jan; 85(1):. PubMed ID: 30741514
[TBL] [Abstract][Full Text] [Related]
19. Financial protection of households against health shocks in Greece during the economic crisis.
Chantzaras AE; Yfantopoulos JN
Soc Sci Med; 2018 Aug; 211():338-351. PubMed ID: 30015243
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
